Sideroblastic anemia risk factors: Difference between revisions
Nazia Fuad (talk | contribs) No edit summary |
Nazia Fuad (talk | contribs) |
||
| Line 17: | Line 17: | ||
** Lead toxicity | ** Lead toxicity | ||
=== Less Common Risk Factors | === Less Common Risk Factors === | ||
* Less common risk factors in the development of sideroblastic anemia are | * Less common risk factors in the development of sideroblastic anemia are<ref name="pmid21632840" /> | ||
** Drugs | ** Drugs | ||
**** Isoniazid | **** Isoniazid | ||
Revision as of 18:34, 10 August 2018
|
Sideroblastic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sideroblastic anemia risk factors On the Web |
|
American Roentgen Ray Society Images of Sideroblastic anemia risk factors |
|
Risk calculators and risk factors for Sideroblastic anemia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nazia Fuad M.D.
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Common risk factors in the development of sideroblastic anemia are male gender (X-linked SA) family history hreditary SAcronic alcohol abuse Less common risk factors in the development of sideroblastic anemia areDrugsisoniazid Pyrazinamide Chloramphenicol Cycloserine Azathioprine Copper deficiency Pyridoxine deficiency Hypothermia affecting mitochondrial functions
Risk Factors
Common Risk Factors
- Common risk factors in the development of sideroblastic anemia are [1]
- Male gender (X-linked SA)
- Family history of hereditary SA
- Chronic alcohol abuse
- Lead toxicity
Less Common Risk Factors
- Less common risk factors in the development of sideroblastic anemia are[1]
- Drugs
- Isoniazid
- Pyrazinamide
- Chloramphenicol
- Cycloserine
- Azathioprine
- Copper deficiency
- Pyridoxine deficiency
- Hypothermia affecting mitochondrial functions
- High dose zinc supplements
- Drugs
References
- ↑ 1.0 1.1 Cazzola M, Invernizzi R (June 2011). "Ring sideroblasts and sideroblastic anemias". Haematologica. 96 (6): 789–92. doi:10.3324/haematol.2011.044628. PMC 3105636. PMID 21632840.